• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of blood pressure variability on the prediction of cancer therapy-related cardiovascular toxicity in patients with multiple myeloma.

作者信息

Morimoto Satoshi, Ichihara Atsuhiro

机构信息

Department of Medicine, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.

Division of Hormonal Medicine and Bioregulatory Science, Department of Medicine, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

Hypertens Res. 2025 Jun;48(6):2005-2006. doi: 10.1038/s41440-025-02215-x. Epub 2025 Apr 16.

DOI:10.1038/s41440-025-02215-x
PMID:40240871
Abstract
摘要

相似文献

1
Impact of blood pressure variability on the prediction of cancer therapy-related cardiovascular toxicity in patients with multiple myeloma.血压变异性对多发性骨髓瘤患者癌症治疗相关心血管毒性预测的影响。
Hypertens Res. 2025 Jun;48(6):2005-2006. doi: 10.1038/s41440-025-02215-x. Epub 2025 Apr 16.
2
Blood pressure variability as predictor of cancer therapy-related cardiovascular toxicity in patients with Multiple Myeloma.血压变异性作为多发性骨髓瘤患者癌症治疗相关心血管毒性的预测指标。
Hypertens Res. 2025 Apr;48(4):1554-1563. doi: 10.1038/s41440-024-02084-w. Epub 2025 Jan 22.
3
Relation of blood pressure variability to left ventricular function and arterial stiffness in hypertensive patients.高血压患者血压变异性与左心室功能和动脉僵硬度的关系。
Singapore Med J. 2019 Aug;60(8):427-431. doi: 10.11622/smedj.2019030. Epub 2019 Mar 11.
4
Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: Early in vivo cardiovascular effects.使用卡非佐米进行不可逆蛋白酶体抑制作为新诊断多发性骨髓瘤患者的一线治疗：早期体内心血管效应。
Eur J Pharmacol. 2018 Nov 5;838:85-90. doi: 10.1016/j.ejphar.2018.09.014. Epub 2018 Sep 7.
5
Short-Term Proteasome Inhibition: Assessment of the Effects of Carfilzomib and Bortezomib on Cardiac Function, Arterial Stiffness, and Vascular Reactivity.短期蛋白酶体抑制：卡非佐米和硼替佐米对心脏功能、动脉僵硬度和血管反应性影响的评估
Biology (Basel). 2024 Oct 21;13(10):844. doi: 10.3390/biology13100844.
6
Arterial Stiffness: A Strong Determinant of Abnormal Cardiac Magnetic Resonance Imaging in an Untreated Hypertensive Population.动脉僵硬度：未经治疗的高血压人群中心脏磁共振成像异常的强决定因素。
Vasc Health Risk Manag. 2025 Apr 24;21:269-278. doi: 10.2147/VHRM.S507356. eCollection 2025.
7
The impact of blood pressure variability on subclinical ventricular, renal and vascular dysfunction, in patients with hypertension and diabetes.血压变异性对高血压合并糖尿病患者亚临床心室、肾脏及血管功能障碍的影响。
Maedica (Bucur). 2013 Jun;8(2):129-36.
8
The Efficacy of Ambulatory Blood Pressure Monitoring-Derived Indices in Predicting Organ Damage in Patients With Hypertension.动态血压监测衍生指标在预测高血压患者器官损害中的效能
Cureus. 2025 Jan 15;17(1):e77457. doi: 10.7759/cureus.77457. eCollection 2025 Jan.
9
Cardiovascular Toxicity of Proteasome Inhibitors in Multiple Myeloma Therapy.蛋白酶体抑制剂在多发性骨髓瘤治疗中的心血管毒性
Curr Probl Cardiol. 2023 Mar;48(3):101536. doi: 10.1016/j.cpcardiol.2022.101536. Epub 2022 Dec 5.
10
Blood pressure variability, nocturnal heart rate variability and endothelial function predict recurrent cerebro-cardiovascular events following ischemic stroke.血压变异性、夜间心率变异性和内皮功能可预测缺血性中风后复发性心脑血管事件。
Front Cardiovasc Med. 2023 Nov 16;10:1288109. doi: 10.3389/fcvm.2023.1288109. eCollection 2023.

本文引用的文献

1
Blood pressure variability as predictor of cancer therapy-related cardiovascular toxicity in patients with Multiple Myeloma.血压变异性作为多发性骨髓瘤患者癌症治疗相关心血管毒性的预测指标。
Hypertens Res. 2025 Apr;48(4):1554-1563. doi: 10.1038/s41440-024-02084-w. Epub 2025 Jan 22.
2
Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: State-of-the-Art Review.蛋白酶体抑制剂的心血管毒性：潜在机制与管理策略：最新综述
JACC CardioOncol. 2023 Feb 21;5(1):1-21. doi: 10.1016/j.jaccao.2022.12.005. eCollection 2023 Feb.
3
Management of Cancer Therapeutics-Related Cardiac Dysfunction.
癌症治疗相关心脏功能障碍的管理。
Heart Fail Clin. 2018 Oct;14(4):553-567. doi: 10.1016/j.hfc.2018.06.004. Epub 2018 Aug 18.
4
Meta-analysis of incidence and risk of peripheral neuropathy associated with intravenous bortezomib.与静脉注射硼替佐米相关的周围神经病变发生率及风险的荟萃分析
Support Care Cancer. 2015 Sep;23(9):2813-24. doi: 10.1007/s00520-015-2648-2. Epub 2015 Feb 13.
5
The relationships between visit-to-visit blood pressure variability and renal and endothelial function in chronic kidney disease.慢性肾脏病中就诊间血压变异性与肾脏及内皮功能的关系。
Hypertens Res. 2015 Mar;38(3):193-8. doi: 10.1038/hr.2014.163. Epub 2014 Dec 4.
6
Visit-to-visit blood pressure variability and carotid artery atherosclerosis: heart rate was not a confounder.就诊间血压变异性与颈动脉粥样硬化：心率并非混杂因素。
Hypertension. 2011 Sep;58(3):e16. doi: 10.1161/HYPERTENSIONAHA.111.176826. Epub 2011 Aug 1.
7
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.血压变异性、收缩压最大值和偶发性高血压的预后意义。
Lancet. 2010 Mar 13;375(9718):895-905. doi: 10.1016/S0140-6736(10)60308-X.